Align Technology, Inc. ALGN
146.78
1.15
0.79%
as of 25 Sep
- Market cap
- $10.4B
- P/E
- 25.5×
Follow ALGN
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Align Technology, Inc. (ALGN) Net margin
Align Technology, Inc.'s net margin over the twelve months to 30 June 2026 was 9.99%, down 0.2 percentage points from fiscal 2025 (10.2%). Over the past ten years it has ranged from 9.68% (fiscal 2022) to 71.8% (fiscal 2020); the current reading is higher than 18% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of 0.00%.
Net margin, annual
Annual
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | 10.2% | (0.37) |
| FY2024 | 10.5% | (0.98) |
| FY2023 | 11.5% | 1.84 |
| FY2022 | 9.68% | (9.85) |
| FY2021 | 19.5% | (52.31) |
| FY2020 | 71.8% | 53.44 |
| FY2019 | 18.4% | (1.95) |
| FY2018 | 20.4% | 4.64 |
| FY2017 | 15.7% | (1.86) |
| FY2016 | 17.6% | 0.54 |
Quarterly
| Period | Net margin | Change (points) |
|---|---|---|
| Jun 2026 | 10.3% | (0.59) |
| Mar 2026 | 10.8% | (2.12) |
| Dec 2025 | 13.0% | 7.26 |
| Sep 2025 | 5.70% | (6.61) |
| 42 more quarters | Free account |
Against its own ten years
Low 9.68%
High 71.8%
Ten-year median
17.0%
Current reading's percentile
18
Net margin against peers
| Company | Net margin |
|---|---|
| SOLV Solventum Corporation compare | 17.3% |
| COO The Cooper Companies, Inc. compare | 13.5% |
| STVN Stevanato Group S.p.A. compare | 11.0% |
| ALGN Align Technology, Inc. | 9.99% |
| ATR AptarGroup, Inc. compare | 9.22% |
| RGEN Repligen Corporation compare | 5.29% |
| BLCO Bausch + Lomb Corporation compare | −3.21% |
| AVTR Avantor, Inc. compare | −8.81% |
| BAX Baxter International Inc. compare | −9.27% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.55% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on ALGN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement